Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.

Hoffbrand's Postgraduate Haematology, 8th Edition - book cover and information about editors, ISBN, price

Since 1972, Hoffbrand's Postgraduate Haematology has introduced generations of trainees and medical residents to the pathogenesis, clinical and laboratory features, and management of blood disorders.

Editor-in-Chief of this latest edition is Professor Adam Mead. He is based in the MRC Weatherall Institute of Molecular Medicine, where he leads a research group identifying therapeutic strategies for myeloid blood cancers. He also looks after patients with myeloid malignancies at Oxford University Hospitals NHS Foundation Trust.

He said: 'Haematology remains at the forefront of the application of advances in molecular biology to the management of human disease. It is a huge honour to take on the role of Editor-in-Chief of Postgraduate Haematology. I hope that it will prove a useful repository of authoritative information for all those faced with the challenge of keeping up to date with an increasingly complex landscape across the wonderfully diverse areas encompassed by clinical and laboratory haematology.'

The book is intended not only for postgraduate trainees or residents in haematology, but also for clinicians and practitioners looking for a reference work on the subject and a guide to the latest research. It includes:

  • 57 chapters written by international experts in their respective fields
  • Colour illustrations and photomicrographs of blood cells and tissues throughout
  • New sections analysing recent advances in next generation sequencing, genome editing, clonal haematopoiesis, anticoagulant drugs, and diagnostic laboratory tools
  • Companion website with downloadable figures and other tools

Read more about the book on Wiley's website

Recent stories

New technology helps decode the genetic changes behind disease

Researchers from the Milne, Hughes and Davies Groups have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulations to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

Professor Bethan Psaila wins ISEH Janet Rowley Award

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

A summer of science and engagement

This summer, researchers at the MRC WIMM have taken part in a variety of public engagement activities, leading a stand at Cheltenham Science Festival and welcoming students for the Institute's summer work experience programme.